Illumina, Inc. vs Pfizer, Inc. — Stock Comparison

ILMN
Illumina, Inc.
$135.78
▲ 7.13%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Illumina, Inc.
ILMN6.9/10vs 6.5/10

Q·Score Breakdown

6.9
Neutral
Overall
6.5
Neutral
8.5
Quality
7.4
7.6
Health
7
6.3
Growth
5.6
6
Valuation
6.7
5.2
Sentiment
5.2
ILMN

High-quality business with 34% return on equity and 19% profit margins.

analyst sentiment is cautious.

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $138.94 (+2.3%)
17 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

ILMN
PFE
24.7×
Trailing P/E
19.4×
23.0×
Forward P/E
9.4×
19.4%
Profit Margin
12.4%
68.4%
Gross Margin
75.8%
33.8%
ROE
8.9%
4.8%
Revenue Growth
-1.2%
6.1%
Earnings Growth
1.49
Beta
0.39
Price / Book
$20.6B
Market Cap
$149.8B
$74 – $156
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →